Genmab A (GMAB) Interest & Investment Income (2018 - 2026)

Genmab A (GMAB) has reported Interest & Investment Income for 9 consecutive years, with $59.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income fell 76.68% year-over-year to $59.0 million; the trailing twelve-month figure through Jun 2026 stood at $668.0 million (down 30.85% YoY), and the FY2025 full-year result was $408.0 million, down 36.74% from the prior year.
• Interest & Investment Income grew to $59.0 million in Q2 2026 per GMAB's latest filing, from $44.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $1.0 billion in Q3 2023 and bottomed at -$782.0 million in Q4 2023.
• Historically, Interest & Investment Income has averaged $164.8 million across 5 years, with a median of $157.5 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Interest & Investment Income jumped 661.74% in 2024, then tumbled 76.68% in 2026.
• Over 5 years, Interest & Investment Income stood at $147.0 million in 2022, then plunged by 631.96% to -$782.0 million in 2023, then soared by 141.94% to $328.0 million in 2024, then retreated by 4.88% to $312.0 million in 2025, then plunged by 81.09% to $59.0 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $59.0 million, $44.0 million, and $312.0 million for Q2 2026, Q1 2026, and Q3 2025 respectively.